The Allogeneic Effect in Non-Hodgkin's Lymphoma

References

• Thomas, E.D., Storb, R., Clift, R.A., Fefer, A., Johnson, L., Neiman, P.E., et al. (1975) "Bone-marrow transplantation", New England Journal of Medicine, 292, 832–843, 895–902.
   PubMed Web of Science ®Google Scholar
• Jemal, A., Thomas, A., Murray, T. and Thun, M. (2002) "Cancer statistics, 2002", CA: a Cancer Journal for Clinicians, 52, 23–47.
   PubMed Web of Science ®Google Scholar
• Hosing, C. and Champlin, R.E. (2002) "The choice of allogeneic or autologous hematopoietic transplantation for NHL", Cytotherapy, 4, 259–269.
   Google Scholar
• Kluin-Nelemans, H.C., Zagonel, V., Anastasopoulou, A., Bron, D., Roozendaal, K.J., Noordijk, E.M., et al. (2001) "Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomised phase III EORTC study", Journal of the National Cancer Institute, 93, 22–30.
   PubMed Web of Science ®Google Scholar
• Linch, D.C., Yung, L., Smith, P., Maclennan, K., Jack, A., Hancock, B., et al. (2002) "A randomised trial of CHOP x vs CHOP x 3 + BEAM + ASCT in 457 patients with poor prog-nosis histologically aggressine non Hodgkin's lymphoma", Annals of Oncology, 136–8[abstract 85].
   Google Scholar
• Weiden, P.L., Flournoy, N., Thomas, E.D., Prentice, R., Fefer, A., Buckner, C.D., et al. (1979) "Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts", New England Journal of Medicine, 300, 1068 — 1073.
   Google Scholar
• Weiden, P.L., Sullivan, K.M., Flournoy, N., Storb, R. and Thomas, E.D. (1981) "Antileukemic effect of chronic graft-versus-host disease. Contribution to improved survival after allogeneic marrow transplantation", New England Journal of Medicine, 304, 1529 — 1533.
   Google Scholar
• van Besien, K.W., de Lima, M., Giralt, S.A., Moore, D.F. Jr, Khouri, IF., Rondon, G., et al. (1997) "Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect", Bone Marrow Transplantation, 19, 977 — 982.
   PubMed Web of Science ®Google Scholar
• Zittoun, R.A., Mandelli, F., Willemze, R., de Witte, T., Labar, B., Resegotti, L., et al. (1995) "Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia", New England Journal of Medicine, 332, 217–223.
   Google Scholar
• Gorin, N.C., Labopin, M., Fouillard, L., Meloni, G., Frassoni, F., Iriondo, A., et al. (1996) "Retrospective evaluation of autologous bone marrow transplantation vs. allogeneic bone marrow trans-plantation from an HLA identical related donor in acute myelocytic leukemia", Bone Marrow Transplantation, 18, 111 — 117.
   Google Scholar
• Fefer, A., Sullivan, K.M., Weiden, P., et al. (1987) Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation. In Cellular Immunotherapy of Cancer, edited by R.L. Truit, R.P. Gale and M.M. Bortin. Pp. 401–408. New York: Alan R Liss, Inc.
   Google Scholar
• Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.J., et al. (1990) "Graft-versus-leukemia reactions after bone marrow transplantation", Blood, 75, 555–562.
   Google Scholar
• Porter, D.L., Roth, M.S., McGarigle, C., Ferrara, J.L. and Antin, J.H. (1994) "Induction of graft-versus-host disease as immunother-apy for relapsed chronic myeloid leukemia", New England Journal of Medicine, 330, 100— 106.
   Google Scholar
• Kolb, H.J., Schattenberg, A., Goldman, J.M., Hertenstein, B., Jacobsen, N., Arcese, W., et al. (1995) "Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia, Blood 86, 2041 —2050.
   Google Scholar
• Gribben, J.G., Freedman, AS., Neuberg, D., Roy, D.C., Blake, K.W., Woo, S.D., et al. (1991) "Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma", New England Journal of Medicine, 325, 1525— 1533.
   Google Scholar
• Schouten, H.C., Kvaloy, S., Sydes, M., Qian, W. and Fayers, P.M. (2000) "The CUP trial: a randomized study analyzing the efficacy of high dose therapy and purging in low-grade non-Hodgkin's lymphoma (NHL)", Annals of Oncology, 11\(Suppl. 1), 91–94.
   PubMed Web of Science ®Google Scholar
• Peniket, A.J., Ruiz De Elvira, M.C., Taghipour, G., Cordonnier, C., Gluckman, E., de Witte, T., et al. European Bone Marrow Transplantation (EBMT) Lymphoma Registry. (2003) "An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation", Bone Marrow Transplantation, 31, 667 — 678.
   PubMedGoogle Scholar
• Morris, E., Thomson, K., Craddock, C., Milligan, D., Murray Smith, G., Parker, A., et al. (2002) "Long-term follow-up of an alemtuzumab (CAMPATH-1H)-containing reduced intensity allo-geneic transplant regimen for non-Hodgkin's lymphoma (NHL)", Blood, 100, 40a [abstract 139].
   Google Scholar
• Kottaridis, P.D., Milligan, D.W., Chopra, R., Chakraverty, R.K., Chakrabarti, S., Robinson, S., et al. (2000) "In vivo Campath 1H prevents graft versus host disease following non myeloablative stem cell transplantation", Blood, 96, 2419–2425.
   PubMed Web of Science ®Google Scholar
• Lush, R.J., Haynes, A.P., Byrne, J.L., Cull, G.M., Carter, G.I., Pagliuca, A., et al. (2001) "Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-Campath ( + /—fludar-abine) conditioning combined with post-transplant donor-lympho-cyte infusion", Cytotherapy, 3, 203–210.
   Google Scholar
• Craddock, C., Bardy, P., Kreiter, S., Johnston, R., Apperley, J., Marks, D., et al. (2000) "Engraftment of T cell depleted allogeneic stem cells using a reduced intensity conditioning regimen", British Journal of Haematology, 111, 797–800.
   Google Scholar
• McSweeney, P.A., Niederwieser, D., Shizuru, J.A., Sandmaier, B.M., Molina, A.J., Maloney, D.G., et al. (2001) "Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-host-tumor effects", Blood, 97, 3390— 3400.
   Google Scholar
• Mattsson, J., Uzunel, M., Brune, M., Hentschke, P., Barkholt, L., Stierner, U., et al. (2001) "Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation", British Journal of Haematology, 115, 935–944.
   Google Scholar
• Mackinnon, S., Papadopoulos, E.B., Carabasi, M.H., Reich, L., Collins, N.H., Boulad, F., et al. (1995) "Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft versus leukaemia responses from graft versus host disease", Blood, 86, 1261–1268.
   Google Scholar
• Dazzi, F., Szydlo, R.M., Cross, N.C., Craddock, C., Kaeda, J., Kanfer, E., et al. (2000) "Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia", Blood, 96, 2712— 2716.
   Google Scholar
• Collins, R.H., Shpilberg, 0., Drobyski, W.R., Porter, D.L., Giralt, S., Champlin, R., et al. (1997) "Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation", Journal of Clinical Oncology, 15, 433–444.
   PubMed Web of Science ®Google Scholar
• Lokhorst, H.M., Schattenberg, A., Cornelissen, J.J., Thomas, L.L. and Verdonck, L.F. (1997) "Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation", Blood, 90, 4206–4211.
   Google Scholar
• Alyea, E.P., Soiffer, R.J., Canning, C., Neuberg, D., Schlossman, R., Pickett, C., et al. (1998) "Toxicity and efficacy of defined doses of CD4( +) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant", Blood, 91, 3671–3680.
   PubMed Web of Science ®Google Scholar
• Marks, DI., Lush, R., Cavenagh, J., Milligan, D.W., Schey, S., Parker, A., et al. (2002) "The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation", Blood, 100, 3108–3114.
   Google Scholar
• Robinson, S.P., Goldstone, A.H., Mackinnon, S., Carella, A., Russell, N., de Elvira, CR., et al. Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation. (2002) "Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplanta-tion", Blood, 100, 4310–4316.
   PubMed Web of Science ®Google Scholar
• Romaguera, J.E., Khouri, IF., Kantarjian, H.M., Hagemeister, F.B., Rodriguez, MA., McLaughlin, P., et al. (2000) "Untreated aggressive mantle cell lymphoma: results with intensive chemother-apy without stem cell transplant in elderly patients", Leukemia and Lymphoma, 39, 77 — 85.
   Google Scholar